Suzhen Yan

585 total citations
8 papers, 492 citations indexed

About

Suzhen Yan is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Suzhen Yan has authored 8 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Suzhen Yan's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (2 papers). Suzhen Yan is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (2 papers). Suzhen Yan collaborates with scholars based in China. Suzhen Yan's co-authors include Chuanxin Wang, Yujiao Xie, Lili Wang, Lutao Du, Xiumei Jiang, Weili Duan, Weili Duan, Yongmei Yang, Juan Li and Qingliang Wang and has published in prestigious journals such as Cell Death and Disease, Oncotarget and Biomedicine & Pharmacotherapy.

In The Last Decade

Suzhen Yan

8 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzhen Yan China 8 435 402 61 48 36 8 492
Sariat Ibrahim United States 6 451 1.0× 492 1.2× 87 1.4× 46 1.0× 33 0.9× 8 557
Tuo Zheng China 5 474 1.1× 461 1.1× 67 1.1× 44 0.9× 34 0.9× 9 574
Kunhou Yao China 11 350 0.8× 357 0.9× 47 0.8× 36 0.8× 53 1.5× 24 446
Jaroslav Juráček Czechia 13 334 0.8× 316 0.8× 61 1.0× 17 0.4× 28 0.8× 29 420
Qiang Zhen China 10 339 0.8× 326 0.8× 31 0.5× 24 0.5× 36 1.0× 13 404
Xiaoyong Cai China 10 236 0.5× 223 0.6× 47 0.8× 34 0.7× 54 1.5× 25 344
Jinsei Miyoshi Japan 8 196 0.5× 312 0.8× 75 1.2× 28 0.6× 76 2.1× 17 434
Chongguo Zhang China 7 366 0.8× 414 1.0× 43 0.7× 34 0.7× 35 1.0× 8 474
Julia Humberg Germany 3 476 1.1× 478 1.2× 23 0.4× 41 0.9× 23 0.6× 5 524

Countries citing papers authored by Suzhen Yan

Since Specialization
Citations

This map shows the geographic impact of Suzhen Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzhen Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzhen Yan more than expected).

Fields of papers citing papers by Suzhen Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzhen Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzhen Yan. The network helps show where Suzhen Yan may publish in the future.

Co-authorship network of co-authors of Suzhen Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Suzhen Yan. A scholar is included among the top collaborators of Suzhen Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzhen Yan. Suzhen Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Li, Peilong, Qi Mi, Suzhen Yan, et al.. (2023). Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-β2 signaling axis. Cell Death and Disease. 14(1). 59–59. 22 indexed citations
2.
Yan, Suzhen, Lutao Du, Xiumei Jiang, et al.. (2020). <p>Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma</p>. Cancer Management and Research. Volume 12. 9753–9763. 31 indexed citations
3.
Wang, Lili, Weili Duan, Suzhen Yan, Yujiao Xie, & Chuanxin Wang. (2019). Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer. Biomedicine & Pharmacotherapy. 113. 108758–108758. 60 indexed citations
4.
Wang, Lili, Lutao Du, Weili Duan, et al.. (2018). Overexpression of long noncoding RNA NORAD in colorectal cancer associates with tumor progression. OncoTargets and Therapy. Volume 11. 6757–6766. 35 indexed citations
5.
Xie, Yujiao, Yi Zhang, Lutao Du, et al.. (2018). Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer. Molecular Oncology. 12(5). 648–658. 128 indexed citations
6.
Du, Lutao, Weili Duan, Xiumei Jiang, et al.. (2018). Cell‐free lncRNA expression signatures in urine serve as novel non‐invasive biomarkers for diagnosis and recurrence prediction of bladder cancer. Journal of Cellular and Molecular Medicine. 22(5). 2838–2845. 51 indexed citations
7.
Wang, Rui, Lutao Du, Xiaoyun Yang, et al.. (2016). Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer. Journal of Cancer Research and Clinical Oncology. 142(11). 2291–2301. 61 indexed citations
8.
Duan, Weili, Lutao Du, Xiumei Jiang, et al.. (2016). Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. Oncotarget. 7(48). 78850–78858. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026